As we did last year, Senior Living Residences (SLR), www.SeniorLivingResdidences.com, is teaming up with its academic affiliate, the Boston University Alzheimer’s Disease Center (BU ADC) www.bu.edu/alzresearch , for the Alzheimer’s Association’s annual Memory Walk, www.alz.org/memorywalk. Memory Walk is the Alzheimer’s Association’s largest fundraiser and public relations event of the year.

Out team will include faculty, professional, and volunteers from both SLR and the BUADC.  Our combined goal this year is to raise more than $10,000 for research, education and care in the fight against Alzheimer’s disease.

If you’d like to walk with us and join our team, please visit the team page at, www.buadcmemorywalk.com. Or, tell us about your own team. Together, we can take steps to end Alzheimer’s disease.

Whenever I do a family or professional training , I ask the audience members to consider what remains when someone is living with Alzheimer’s disease, as compared to the many losses the individual is experiencing.

This past week I spent some time with residents in the Compass Memory Support at the BayView Assisted Living, a community owned by Senior Living Residences. One of the residents had some difficulty walking into the dining room at lunchtime. The associates quickly offered her assistance and she rested in a chair for a few minutes before continuing in to have her meal.

Another resident, who had watched the scene closely, approached the staff and offered his services. Once he was assured that everything was fine, he went in to have his own lunch.

I spoke to Jennifer Hoadley, the Program Director, about the resident who had approached to offer help, commenting on his composure, true concern, and fast action. She said, “he is a former Boston firefighter and is always right there when anyone needs assistance.” Although he is now living with Alzheimer’s disease, his lifelong call to the service and safety of others remains, unchanged by his disease.

A recent study from the University of Central Florida (UCF), provides new information about the earliest stages of Alzheimer’s disease, where preventative treatment is possible.

Among scientists and many lay people, it is well known that beta-amyloid is a destructive force to nerve cells in people suffering from Alzheimer’s disease. Beta-amyloid builds up in the brain, clumping in neurons and forming damaging deposits knows as plaque. This plaque is one of the hallmarks of Alzheimer’s disease.

In the disease process, the beta-amyloid damages and eventually kills neurons, brain cells. Many research studies have focused on the damaged nerve cells in trying to understand this process towards seeking a possible prevention and treatment.

In this new study, researchers from UCF looked at smaller amounts of beta-amyloid and its effect on healthy nerve cells. The scientists found that this more moderate exposure to the beta-amyloid has an effect on the cells, preventing the normal transfer of electronic signals in the brain.

The discovery is important in that it provides evidence that changes are occurring in the brain well before there are any noted changes to memory or behavior, that is, symptoms of the disease. This information may be valuable in the quest for a treatment that works in the earliest stages of the disease, suitable for an individual with the mild cognitive impairment.

More research is needed to fully understand the role of beta-amyloid in Alzheimer’s disease as well as potential treatments.

Have you ever heard the term Mild Cognitive Impairment (MCI)?

More and more, I see this term used for the general public: to describe newsworthy findings of studies about memory and aging, in educational materials from leading organizations like the Alzheimer’s Association, and from neurologists caring for people experiencing memory loss.

MCI refers to the stage between the cognitive decline associated with normal aging and the more serious changes associated with Alzheimer’s disease, marked by progressive loss of memory and day to day functional abilities.

Researchers and scientist are particularly interested in studying people with MCI as they may be seeing Alzheimer’s disease (AD) at its earliest stage. People with MCI are an important part of research studies seeking information about biomarkers, risk factors, and prevention of AD.

Senior Living Residences, www.seniorlivingresidences, is currently implementing a number of cognitive health initiatives to help people living with the memory changes associated with MCI and the earliest stages of Alzheimer’s disease.

Visit this blog again for information on the diagnosis, treatment, and services available for people with Mild Cognitive Impairment.